Comparative Assessment of Tedizolid Tissue Penetration and Pharmacokinetic Profile Between Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Trial Profile

Comparative Assessment of Tedizolid Tissue Penetration and Pharmacokinetic Profile Between Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Tedizolid (Primary)
  • Indications Bacteraemia; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections; Wound infections
  • Focus Therapeutic Use
  • Acronyms TZD MicroD
  • Most Recent Events

    • 25 Apr 2017 Results of pharmacokinetic data from diabetic patients with lower limb infection (n=6) presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 23 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 23 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top